Andrew Hoffman has been named the next Gilbert S. Kahn Dean of Veterinary Medicine at the University of Pennsylvania, effective Aug. 1.

Ron Ozio ・February 28, 2018

A group of Social Policy and Practice interns provides social and emotional support for patients diagnosed with memory loss or other neurological or physical impairments.

Julie McWilliams ・February 23, 2018

Dramatic calorie restriction, diets reduced by 40 percent of a normal calorie total, have long been known to extend health span, the duration of disease-free aging, in animal studies, and even to extend life span in most animal species examined.

Katherine Unger Baillie ・February 22, 2018

Population-based epidemiological studies provide new opportunities for innovation and collaboration among researchers addressing pressing global-health concerns.

Katherine Unger Baillie ・February 21, 2018

A hundred years ago, the flu pandemic hit Philadelphia. Today, Penn researchers are working to prevent a future outbreak.

Katherine Unger Baillie, Michele W. Berger ・February 21, 2018

Researchers at the University of Pennsylvania’s School of Engineering and Applied Science have demonstrated the feasibility of their “organ-on-a-chip” platform in studying how drugs are transported across the human placental barrier.

Ali Sundermier, Evan Lerner ・February 20, 2018

In many modern animated movies, the trick to achieving realistic movements for individual characters and objects lies in motion-capture technology. This process often involves someone wearing a tracking suit covered in small, colored balls while a camera captures the position of those colored balls, which is then used to represent how the person is moving.

Ali Sundermier February 12, 2018

Globally renowned bioethicist Ezekiel J.

Katie Delach, Amanda Mott ・February 7, 2018

Performance can be enhanced by as much as 15 percent, according to a study by Penn neuroscientists published in Nature Communications. It is the first time such a connection has been made.

Michele W. Berger ・February 6, 2018

As part of a breast-cancer diagnosis, doctors analyze the tumor to determine which therapies might best attack the malignancy. But for patients whose cancer is triple-negative — that is, lacking receptors for estrogen, progesterone and Her2 — the options for treatment dwindle. Triple-negative cancers, or TNBC, also tend to be more aggressive than other cancer subtypes.

Katherine Unger Baillie ・February 2, 2018